We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BZFD icon
3376
BuzzFeed
BZFD
$90.3M
$187 ﹤0.01%
88
– –
2023 Q4
5 quarters
HUCK icon
3377
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$151M
$186 ﹤0.01%
+24
New +$192
2025 Q1
0 quarters
EGO icon
3378
Eldorado Gold
EGO
$9.45B
$185 ﹤0.01%
11
– –
2022 Q1
12 quarters
ETNB icon
3379
DELISTED
89bio
ETNB
$182 ﹤0.01%
+25
New +$219
2025 Q1
0 quarters
DCGO icon
3380
DocGo
DCGO
$27.9M
$180 ﹤0.01%
68
+48
+240% +$193
2024 Q4
1 quarter
LAZR icon
3381
DELISTED
Luminar Technologies
LAZR
$178 ﹤0.01%
+33
New +$200
2025 Q1
0 quarters
ALLK icon
3382
DELISTED
Allakos
ALLK
$175 ﹤0.01%
770
– –
2020 Q1
20 quarters
LSPD icon
3383
Lightspeed Commerce
LSPD
$1.41B
$175 ﹤0.01%
20
– –
2023 Q1
8 quarters
TPST icon
3384
Tempest Therapeutics
TPST
$10.7M
$174 ﹤0.01%
18
– –
2024 Q2
3 quarters
ALDX icon
3385
Aldeyra Therapeutics
ALDX
$44.5M
$173 ﹤0.01%
+30
New +$177
2025 Q1
0 quarters
NRGV icon
3386
Energy Vault
NRGV
$556M
$172 ﹤0.01%
247
– –
2023 Q1
8 quarters
AAOI icon
3387
Applied Optoelectronics
AAOI
$7.11B
$169 ﹤0.01%
11
+6
+120% +$151
2024 Q4
1 quarter
PFLT icon
3388
PennantPark Floating Rate Capital
PFLT
$660M
$168 ﹤0.01%
15
– –
2024 Q2
3 quarters
ALLO icon
3389
Allogene Therapeutics
ALLO
$463M
$166 ﹤0.01%
114
-107
-48% -$202
2024 Q2
3 quarters
FC icon
3390
Franklin Covey
FC
$205M
$166 ﹤0.01%
6
– –
2024 Q3
2 quarters
FLWS icon
3391
1-800-Flowers.com
FLWS
$184M
$165 ﹤0.01%
28
– –
2020 Q2
19 quarters
TLRY icon
3392
Tilray
TLRY
$474M
$165 ﹤0.01%
25
– –
2018 Q3
26 quarters
CDNA icon
3393
CareDx
CDNA
$3.45B
$160 ﹤0.01%
9
– –
2024 Q4
1 quarter
STOK icon
3394
Stoke Therapeutics
STOK
$1.59B
$160 ﹤0.01%
+24
New +$224
2025 Q1
0 quarters
AROW icon
3395
Arrow Financial
AROW
$682M
$158 ﹤0.01%
6
– –
2023 Q1
8 quarters
NEWT icon
3396
NewtekOne
NEWT
$316M
$155 ﹤0.01%
+13
New +$164
2025 Q1
0 quarters
SIFY icon
3397
Sify Technologies
SIFY
$851M
$146 ﹤0.01%
+34
New +$136
2025 Q1
0 quarters
SVV icon
3398
Savers
SVV
$1.55B
$145 ﹤0.01%
21
-1
-5% -$9
2024 Q4
1 quarter
XPOF icon
3399
Xponential Fitness
XPOF
$195M
$142 ﹤0.01%
17
+3
+21% +$42
2024 Q4
1 quarter
DMRC icon
3400
Digimarc Corp
DMRC
$151M
$141 ﹤0.01%
11
-36
-77% -$1.03K
2024 Q2
3 quarters

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.